INmune Bio(INMB) - 2024 Q1 - Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Results Conference Call May 9, 2024 4:30 PM ET Company Participants David Moss - Chief Financial Officer Dr. RJ Tesi - Chief Executive Officer and Co-Founder Dr. Mark Lowdell - Chief Scientific Officer Conference Call Participants Tom Shrader - BTIG Joel Beatty - Baird Jason McCarthy - Maxim Group Daniel Carlson - Tailwinds Research Operator Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the presentation, there will be a questio ...